2004
DOI: 10.1016/s0168-8278(03)00479-3
|View full text |Cite
|
Sign up to set email alerts
|

Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

14
91
3
5

Year Published

2005
2005
2017
2017

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 130 publications
(113 citation statements)
references
References 35 publications
14
91
3
5
Order By: Relevance
“…It was reported that obesity and overweight is directly associated with hepatic steatosis in patients (34). Obesity-induced simple steatosis could develop into NASH and then to liver cirrhosis and hepatocellular carcinoma (35).…”
Section: Discussionmentioning
confidence: 99%
“…It was reported that obesity and overweight is directly associated with hepatic steatosis in patients (34). Obesity-induced simple steatosis could develop into NASH and then to liver cirrhosis and hepatocellular carcinoma (35).…”
Section: Discussionmentioning
confidence: 99%
“…24 This finding is supported by evidence that hepatic steatosis in patients with CHC is associated with hepatic inflammation and advanced stages of fibrosis. 21 Leptin also may mediate fibrogenesis. This satiety hormone has been shown to be profibrogenic and up-regulation of leptin signaling may lead to fibrosis progression.…”
Section: Increased Fibrosismentioning
confidence: 99%
“…3,4 Alcohol abuse, hepatitis B virus (HBV) infection, and metabolic liver diseases have emerged as major determinants of clinical decompensation, development of hepatocellular carcinoma (HCC), and survival of patients with compensated cirrhosis. [5][6][7][8] However, lack of cohort enrollment and sufficiently long periods of follow-up might have limited the correct understanding of the natural history and prognostication of hepatitis C virus (HCV)-related cirrhosis-particularly when epiphenomena like ascites, jaundice, and encephalopathy are selected, all of which are indirect indicators of liver function not central to the disease process. 9 In 1986, a cohort of 417 HCCfree patients with compensated cirrhosis of different etiologies was enrolled into a surveillance program for HCC, whose secondary end point was clinical decompensation and patient survival.…”
mentioning
confidence: 99%